Flow cytometric assays for CAR T cell manufacturing and post-infusion monitoring [WEBINAR]

For more information, visit www.miltenyibiotec.com/applic... In this webinar, we will delve into the crucial role of flow cytometry in analyzing and characterizing critical quality attributes of CAR T cell products, including identity, purity, and potency, throughout the manufacturing process. We will also explore how flow cytometry can be used to monitor cell expansion and persistence post-infusion, offering attendees a comprehensive understanding of how this powerful tool can be applied to ensure high-quality CAR T cell products.
Throughout the preclinical development and cell and gene therapy commercialization, analytical assays are essential to produce safe and potent drug products. In this webinar Stephen Wilmes, PhD, delves into the crucial role of flow cytometry in analyzing and characterizing critical quality attributes of CAR T cell products, including identity, purity, and potency, throughout the manufacturing process. He will also explain how flow cytometry can be used to monitor cell expansion and persistence post-infusion, granting a comprehensive understanding of how this powerful tool can be applied to ensure high-quality CAR T cell products. Furthermore, don’t miss the chance to explore new technologies that can further enhance the sensitivity and resolution capabilities of CAR T cell flow cytometry assays.
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,700 employees in 28 countries - all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.